Medicare: Part D plans cover Ozempic for diabetes, certain cardiac, or kidney conditions, but not for weight loss
If there's insulin resistance, if there are, uh, metabolic comorbidities, like there's already pre-diabetes type two diabetes, fatty liver disease, there's elevated cardiovascular risk that [00:41:00] is not improving despite trying everything, doing everything right, then that's when GLP ones are considered
This medication works by mimicking the action of the naturally occurring GLP-1 hormone, enhancing glucose-dependent insulin secretion, suppressing inappropriate glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways
doi: 10.1016/j.chemosphere.2021.132813
Clayman, DMD, MD, FACS, discussed evaluating the link between GLP-1 receptor agonists and thyroid cancer
Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al